On the segmental front, revenue from the Poultry and Poultry Products was Rs 446.63 crore (up 14% YoY), Animal Health Products revenue was Rs 72.57 crore (up 6% YoY) and that from Oilseed was Rs 743.64 crore (up 44% YoY) during the period under review.

Profit before tax in Q4 FY22 stood at Rs 82.23 crore, down by 23% from Rs 106.51 crore in Q4 FY21.

The company recorded 38% fall in net profit to Rs 164.78 crore despite a 41% increase in revenue from operations to Rs 4,400.29 crore in Q4 FY22 over Q4 FY21.

Venky's said that the realizations of poultry and poultry products segment have improved during the quarter ended March 2022.

Profitability of poultry and poultry products segment for the year ended March 2022 has been impacted due to steep increase in prices of poultry feed ingredients as compared to the previous year. While the average cost of maize has gone up by 32%, soya meal has gone up by 78%.

The performance of Animal Health Products and Oilseed segments has been good for the year ended March 2022.

The company's total borrowings aggregated to Rs 191.89 crore as on 31 March 2022 as against Rs 181.66 crore as on 31 March 2021.

The company's board has recommended a dividend of Rs 13 per share for the year ended 31 March 2022.

Venky's (India) is a part of the VH group which is the largest and most integrated poultry player in India with strong presence in poultry broiler as well as layer segment along with sizeable presence in value added segments like animal healthcare products and processed chicken. The group's operations span the entire spectrum of poultry activities from pure-line breeding, grandparent and parent breeding and sale of commercial day-old chicks (DOCs) to contract commercial farming.